SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
284 hedge funds and large institutions have $8.18B invested in Sage Therapeutics in 2019 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 100 increasing their positions, 94 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
0.74% less ownership
Funds ownership: 113.57% → 112.84% (-0.74%)
17% less call options, than puts
Call options by funds: $102M | Put options by funds: $124M
23% less capital invested
Capital invested by funds: $10.6B → $8.18B (-$2.46B)
Holders
284
Holding in Top 10
7
Calls
$102M
Puts
$124M
Top Buyers
| 1 | +$72.5M | |
| 2 | +$52.4M | |
| 3 | +$37M | |
| 4 |
CII
Capital International Inc
Los Angeles,
California
|
+$35M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$28.8M |
Top Sellers
| 1 | -$61.8M | |
| 2 | -$36M | |
| 3 | -$36M | |
| 4 |
Bank of New York Mellon
New York
|
-$33.5M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$28.1M |